Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ALOT compared with ESPR: revenue, margins and what each company keeps, and the suppliers and customers both name
ALOT
AstroNova, Inc.
Change
Mkt cap
Revenue
Revenue
ESPR
Esperion Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ALOT
AstroNova, Inc.
vs
ESPR
Esperion Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ESPR: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ALOT
7
BA
Boeing
customer
LMT
Lockheed
customer
HON
Honeywell International
supplier
—
Honeywell
unlisted
supplier
3 more · ALOT chain
›
Shared
0
No shared counterparties.
Only ESPR
7
PFE
Pfizer
supplier
—
Neopharm
unlisted
customer
—
Otsuka Pharmaceutical
unlisted
customer
—
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Seqirus Pty Ltd (CSL Seqirus)
unlisted
customer
3 more · ESPR chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ALOT, solid
ESPR, dashed
ALOT
AstroNova, Inc.
Change
28.99
▼
−0.01%
· post 29.00
Mkt cap
$224.6M
Revenue
$39M
Q1 FY27
Revenue
$151M
FY26
ESPR
Esperion Therapeutics, Inc.
Change
3.19
▼
−0.16%
· post 3.20
Closed
Aug 26 '26
Mkt cap
$818.6M
Revenue
$80M
Q1 FY26
Revenue
$403M
FY25
vs
Compare
Closed
Aug 26 '26
ALOT
AstroNova, Inc.
vs
ESPR
Esperion Therapeutics, Inc.
28.99
▼
−0.01%
post 29.00
Price
3.19
▼
−0.16%
post 3.20
$224.6M
Mkt cap
$818.6M
Q1 FY27
$39M
Revenue
$80M
Q1 FY26
FY26
$151M
Revenue
$403M
FY25
Change
Change
ALOT
28.99
▼
−0.01%
vs
ESPR
3.19
▼
−0.16%
Closed
Aug 26 '26